Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ENOCHIAN BIOSCIENCES, INC.

(ENOB)
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

ENOCHIAN BIOSCIENCES INC : Other Events, Financial Statements and Exhibits (form 8-K)

08/30/2021 | 01:37pm EDT

Item 8.01. Other Events.

On August 30, 2021, Enochian Biosciences Inc. (the "Company") issued a press release announcing the appointment of Dr. Peter Piot, KCMG, FRCP and Dr. Richard Whitley, MD to the Company's Scientific Advisory Board. A copy of the press release is attached hereto as Exhibit 99.1, and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.




  (d)  Exhibits




Exhibit No.   Description

99.1            Press Release dated August 30, 2021.

© Edgar Online, source Glimpses

All news about ENOCHIAN BIOSCIENCES, INC.
10/18ENOCHIAN BIOSCIENCES ANNOUNCES THE S : The Second Pre-IND in 1 month
PU
10/18ENOCHIAN BIOSCIENCES : Completes FDA Pre-IND for HIV Antiviral Therapy; Shares Down in Pre..
MT
10/18Enochian BioSciences Completes Pre-IND After FDA Comments
DJ
10/18ENOCHIAN BIOSCIENCES ANNOUNCES THE S : The Second Pre-IND in 1 month
AQ
10/15ENOCHIAN BIOSCIENCES : Scientific Advisory Board Member Resigns Due to Conflict with Respo..
PU
10/15ENOCHIAN BIOSCIENCES : Scientific Advisory Board Member Resigns Due to Conflict with Respo..
AQ
10/15Enochian Biosciences, Inc. Announces Resignation of Peter Piot as Chairperson of the Re..
CI
10/12ENOCHIAN BIOSCIENCES : Fireside Chat with Enochian BioSciences' CEO, Dr. Mark Dybul at H.C..
PU
10/12ENOCHIAN BIOSCIENCES : Fireside Chat with Enochian BioSciences' CEO, Dr. Mark Dybul at H.C..
AQ
09/28ENOCHIAN BIOSCIENCES : Sinks 17%, Trading Volume Doubles Daily Average
MT
More news
Financials (USD)
Sales 2021 - - -
Net income 2021 -26,7 M - -
Net cash 2021 13,3 M - -
P/E ratio 2021 -8,77x
Yield 2021 -
Capitalization 472 M 472 M -
EV / Sales 2020 -
EV / Sales 2021 -
Nbr of Employees 11
Free-Float 38,5%
Chart ENOCHIAN BIOSCIENCES, INC.
Duration : Period :
Enochian Biosciences, Inc. Technical Analysis Chart | ENOB | US29350E1047 | MarketScreener
Technical analysis trends ENOCHIAN BIOSCIENCES, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Managers and Directors
Mark Richard Dybul Executive Vice Chairman & Chief Executive Officer
Luisa Puche Chief Financial Officer
Rene Sindlev Chairman
Joseph R. Cohen Director-Research & Discovery
Carl Sandler Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ENOCHIAN BIOSCIENCES, INC.206.44%472
GILEAD SCIENCES, INC.13.11%82 626
WUXI APPTEC CO., LTD.28.00%65 873
BIONTECH SE220.28%63 059
REGENERON PHARMACEUTICALS12.50%56 504
VERTEX PHARMACEUTICALS-23.50%46 905